Literature DB >> 20401596

Rapid methods for testing inhibitors of mycobacterial growth.

Dimitrios Evangelopoulos1, Sanjib Bhakta.   

Abstract

Considering the increased concerns with controlling infectious epidemics such as tuberculosis, a global concerted effort (WHO) is now dead-lined to tackle the emergence of extensive drug resistance through identifying a novel line of therapeutics which will on the one hand shorten the course of treatment and on the other is also expected to be effective against the emerging resistant strains. Major problems with the preclinical drug screening against the uniquely slow-growing pathogen Mycobacterium tuberculosis are either found expensive, time-consuming, or require a highly complex laboratory setup. A rapid and convenient, although relatively inexpensive, method requiring very little consumption of inhibitors within a simple microbiology setup for antimycobacterial screening is thus timely. The spot-culture growth inhibition assay aims to test the biological activity of a number of newly discovered natural products and thousands of novel chemicals synthesized on the basis of basic structural and molecular biology studies. Many different classes of novel chemical entities are now independently prepared around the world by distinguished chemists on the chemical behavior of the group of molecules. To serve the purpose of antimycobacterials screening, we aim to describe a method in this chapter performed in a six-well plate format. This method can also be extended accurately to a 96-well plate format according to the necessity of the project. In addition to evaluating a range of prospective drug candidates, this method would also contribute to elucidate substrates for many putative endogenous pathways through comparing the chemical inhibition with the corresponding genetic modification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401596     DOI: 10.1007/978-1-60327-279-7_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Study on the interaction between isoniazid and bovine serum albumin by fluorescence spectroscopy: the effect of dimethylsulfoxide.

Authors:  Shiraz A Markarian; Mikayel G Aznauryan
Journal:  Mol Biol Rep       Date:  2012-02-12       Impact factor: 2.316

2.  Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay.

Authors:  Juan D Guzman; Dimitrios Evangelopoulos; Antima Gupta; Kristian Birchall; Solomon Mwaigwisya; Barbara Saxty; Timothy D McHugh; Simon Gibbons; John Malkinson; Sanjib Bhakta
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

3.  Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase.

Authors:  Juan D Guzman; Thomas Pesnot; Diana A Barrera; Heledd M Davies; Eleanor McMahon; Dimitrios Evangelopoulos; Parisa N Mortazavi; Tulika Munshi; Arundhati Maitra; Eleanor D Lamming; Richard Angell; Markus C Gershater; Joanna M Redmond; Deborah Needham; John M Ward; Luis E Cuca; Helen C Hailes; Sanjib Bhakta
Journal:  J Antimicrob Chemother       Date:  2015-02-04       Impact factor: 5.790

4.  Antioxidant, antitubercular and cytotoxic activities of Piper imperiale.

Authors:  Luis E Diaz; Diego R Munoz; Rosa E Prieto; Sergio A Cuervo; Diego L Gonzalez; Juan D Guzman; Sanjib Bhakta
Journal:  Molecules       Date:  2012-04-05       Impact factor: 4.411

5.  New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis.

Authors:  Sarentha Chetty; Tom Armstrong; Shalu Sharma Kharkwal; William C Drewe; Cristina I De Matteis; Dimitrios Evangelopoulos; Sanjib Bhakta; Neil R Thomas
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-14

6.  Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target.

Authors:  Arundhati Maitra; Syamasundari Nukala; Rachael Dickman; Liam T Martin; Tulika Munshi; Antima Gupta; Adrian J Shepherd; Kristine B Arnvig; Alethea B Tabor; Nicholas H Keep; Sanjib Bhakta
Journal:  JAC Antimicrob Resist       Date:  2021-03-16

7.  TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis-a meeting report of a Euroscicon conference.

Authors:  Arundhati Maitra; Sanjib Bhakta
Journal:  Virulence       Date:  2014-07-08       Impact factor: 5.882

8.  Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition.

Authors:  Cynthia A Danquah; Eleftheria Kakagianni; Proma Khondkar; Arundhati Maitra; Mukhlesur Rahman; Dimitrios Evangelopoulos; Timothy D McHugh; Paul Stapleton; John Malkinson; Sanjib Bhakta; Simon Gibbons
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

9.  Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification.

Authors:  Samantha L van der Beek; Azul Zorzoli; Ebru Çanak; Robert N Chapman; Kieron Lucas; Benjamin H Meyer; Dimitrios Evangelopoulos; Luiz Pedro S de Carvalho; Geert-Jan Boons; Helge C Dorfmueller; Nina M van Sorge
Journal:  Mol Microbiol       Date:  2019-01-31       Impact factor: 3.501

10.  Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.

Authors:  Julia Solnier; Liam Martin; Sanjib Bhakta; Franz Bucar
Journal:  Molecules       Date:  2020-02-07       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.